$LOXO News
Last published 8mo ago
- 8mo agoCMPXMRKSGENPFE+8Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsightPR NewswireThe biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing...
- 8y agoLOXOLoxo Oncology, Inc. (LOXO) CEO Dr. Josh Bilenker on Q2 2018 Results - Earnings Call TranscriptEarnings Call Transcripts
- 8y agoILMNLOXOIllumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion DiagnosticsBusiness WireSAN DIEGO & STAMFORD, Conn.--(BUSINESS WIRE)--Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) today announced a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling, resulting in a distributable, next-generation sequencing (NGS) based companion diagnostic (CDx) with a pan-cancer indication. The co-development partnership will seek ap ...
- 9y agoLOXOLoxo Oncology's (LOXO) CEO Josh Bilenker on Q3 2017 Results - Earnings Call TranscriptEarnings Call Transcripts